• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾体积测量对多囊肾病预后的预测价值:椭球与手动分割的比较研究。

Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.

机构信息

Division of Nephrology and University Health Network and University of Toronto, Toronto, Ontario, Canada.

Department of Medical Imaging, University Health Network and University of Toronto, Toronto, Ontario, Canada.

出版信息

Sci Rep. 2019 Jul 29;9(1):10996. doi: 10.1038/s41598-019-47206-4.

DOI:10.1038/s41598-019-47206-4
PMID:31358787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6662759/
Abstract

Total kidney volume (TKV) is a validated prognostic biomarker for risk assessment in autosomal dominant polycystic kidney disease (ADPKD). TKV by manual segmentation (MS) is the "gold standard" but is time-consuming and requires expertise. The purpose of this study was to compare TKV-based prognostic performance by ellipsoid (EL) vs. MS in a large cohort of patients. Cross-sectional study of 308 patients seen at a tertiary referral center; all had a standardized MRI with typical imaging of ADPKD. An experienced radiologist blinded to patient clinical results performed all TKV measurements by EL and MS. We assessed the agreement of TKV measurements by intraclass correlation(ICC) and Bland-Altman plot and also how the disagreement of the two methods impact the prognostic performance of the Mayo Clinic Imaging Classification (MCIC). We found a high ICC of TKV measurements (0.991, p < 0.001) between EL vs. MS; however, 5.5% of the cases displayed disagreement of TKV measurements >20%. We also found a high degree of agreement of the individual MCIC risk classes (i.e. 1A to 1E) with a Cohen's weighted-kappa of 0.89; but 42 cases (13.6%) were misclassified by EL with no misclassification spanning more than one risk class. The sensitivity and specificity of EL in distinguishing low-risk (1A-B) from high-risk (1C-E) MCIC prognostic grouping were 96.6% and 96.1%, respectively. Overall, we found an excellent agreement of TKV-based risk assessment between EL and MS. However, caution is warranted for patients with MCIC 1B and 1C, as misclassification can have therapeutic consequence.

摘要

肾脏总体积(TKV)是一种经过验证的用于评估常染色体显性多囊肾病(ADPKD)风险的预后生物标志物。手动分割(MS)的 TKV 是“金标准”,但耗时且需要专业知识。本研究的目的是比较基于椭球(EL)和 MS 的 TKV 预后性能在大型患者队列中的表现。对在三级转诊中心就诊的 308 例患者进行的横断面研究;所有患者均进行了标准 MRI 检查,具有 ADPKD 的典型影像学表现。一位经验丰富的放射科医生在不知道患者临床结果的情况下,通过 EL 和 MS 对所有 TKV 进行了测量。我们通过组内相关系数(ICC)和 Bland-Altman 图评估了 TKV 测量的一致性,并评估了两种方法的差异如何影响 Mayo 临床成像分类(MCIC)的预后性能。我们发现 EL 与 MS 之间的 TKV 测量值具有很高的 ICC(0.991,p<0.001);然而,有 5.5%的病例显示 TKV 测量值差异>20%。我们还发现 MCIC 风险类别(即 1A 至 1E)的个体具有很高的一致性,Cohen 加权kappa 值为 0.89;但是,有 42 例(13.6%)被 EL 错误分类,没有一个风险类别跨越一个以上的风险类别。EL 在区分低风险(1A-B)和高风险(1C-E)MCIC 预后分组方面的敏感性和特异性分别为 96.6%和 96.1%。总体而言,我们发现 EL 和 MS 之间基于 TKV 的风险评估具有极好的一致性。然而,对于 MCIC 1B 和 1C 的患者,需要谨慎,因为错误分类可能会产生治疗后果。

相似文献

1
Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.肾体积测量对多囊肾病预后的预测价值:椭球与手动分割的比较研究。
Sci Rep. 2019 Jul 29;9(1):10996. doi: 10.1038/s41598-019-47206-4.
2
Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging.多囊肾病中 3D 和椭球超声测量全肾体积与磁共振成像的比较。
Clin J Am Soc Nephrol. 2022 Jun;17(6):827-834. doi: 10.2215/CJN.14931121. Epub 2022 Apr 5.
3
Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.应用于常染色体显性多囊肾病患者磁共振图像的肾脏和肝脏自动容积测量。
J Am Soc Nephrol. 2019 Aug;30(8):1514-1522. doi: 10.1681/ASN.2018090902. Epub 2019 Jul 3.
4
Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.在随访磁共振图像上自动测量总肾体积以促进常染色体显性多囊肾病进展的监测。
Nephrol Dial Transplant. 2016 Feb;31(2):241-8. doi: 10.1093/ndt/gfv314. Epub 2015 Aug 31.
5
A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.一种快速高效的半自动工具,用于从 MRI 测量常染色体显性多囊肾病的总肾体积。
Eur Radiol. 2019 Aug;29(8):4188-4197. doi: 10.1007/s00330-018-5918-9. Epub 2019 Jan 21.
6
Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.在多囊肾病模型中小鼠肾脏体积测量方法的准确性和处理时间:半自动肾脏分割的优势。
Am J Physiol Renal Physiol. 2023 Apr 1;324(4):F423-F430. doi: 10.1152/ajprenal.00295.2022. Epub 2023 Feb 16.
7
Total kidney volume in autosomal dominant polycystic kidney disease: intraobserver and interobserver agreement of two methods with MRI.常染色体显性多囊肾病的全肾体积:MRI 两种方法的观察者内和观察者间一致性。
Turk J Med Sci. 2024 Jan 5;54(3):537-544. doi: 10.55730/1300-0144.5820. eCollection 2024.
8
Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment.常染色体显性多囊肾病中全肾体积定量方法的比较用于全面疾病评估
Am J Nephrol. 2017;45(5):373-379. doi: 10.1159/000466709. Epub 2017 Mar 18.
9
A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.深度学习方法自动分割常染色体显性多囊肾病患者的肾脏和外生性囊肿。
J Am Soc Nephrol. 2022 Aug;33(8):1581-1589. doi: 10.1681/ASN.2021111400. Epub 2022 Jun 29.
10
T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.基于 T1 加权和 T2 加权磁共振成像评估常染色体显性多囊肾病患者的总肾体积。
Abdom Radiol (NY). 2018 May;43(5):1215-1222. doi: 10.1007/s00261-017-1285-2.

引用本文的文献

1
Comparison Between the Human-Sourced Ellipsoid Method and Kidney Volumetry Using Artificial Intelligence in Polycystic Kidney Disease.多囊肾病中人源椭球体法与人工智能肾脏体积测量法的比较
J Pers Med. 2025 Aug 20;15(8):392. doi: 10.3390/jpm15080392.
2
Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances.常染色体显性多囊肾病:近期遗传学和临床进展概述
Ren Fail. 2025 Dec;47(1):2492374. doi: 10.1080/0886022X.2025.2492374. Epub 2025 Apr 23.
3
Ultrasound versus magnetic resonance imaging for calculating total kidney volume in patients with ADPKD: a real-world data analysis.

本文引用的文献

1
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.托伐普坦治疗快速进展型常染色体显性多囊肾病的实用指南。
J Am Soc Nephrol. 2018 Oct;29(10):2458-2470. doi: 10.1681/ASN.2018060590. Epub 2018 Sep 18.
2
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.人群测序估算多囊肾病和多囊肝病的患病率。
J Am Soc Nephrol. 2018 Oct;29(10):2593-2600. doi: 10.1681/ASN.2018050493. Epub 2018 Aug 22.
3
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
超声与磁共振成像在计算常染色体显性多囊肾病患者总肾体积中的应用:一项真实世界数据分析
Ultrasound J. 2025 Feb 11;17(1):13. doi: 10.1186/s13089-025-00400-0.
4
Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting.使用双参数最小二乘法拟合提高 ADPKD 患者总肾体积增长率的预测。
Sci Rep. 2024 Jun 14;14(1):13794. doi: 10.1038/s41598-024-62776-8.
5
Non-contrast low-dose CT can be used for volumetry of ADPKD.非增强低剂量 CT 可用于 ADPKD 的容量测量。
BMC Nephrol. 2023 Oct 26;24(1):317. doi: 10.1186/s12882-023-03359-z.
6
Abdominal Imaging in ADPKD: Beyond Total Kidney Volume.常染色体显性多囊肾病的腹部影像学检查:超越总肾体积
J Clin Med. 2023 Aug 5;12(15):5133. doi: 10.3390/jcm12155133.
7
Bone health in autosomal dominant polycystic kidney disease (ADPKD) patients after kidney transplantation.肾移植后常染色体显性多囊肾病(ADPKD)患者的骨骼健康
Bone Rep. 2023 Jan 11;18:101655. doi: 10.1016/j.bonr.2023.101655. eCollection 2023 Jun.
8
Kidney Tumor Segmentation Based on FR2PAttU-Net Model.基于FR2PAttU-Net模型的肾肿瘤分割
Front Oncol. 2022 Mar 17;12:853281. doi: 10.3389/fonc.2022.853281. eCollection 2022.
9
Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study.梅奥影像分类是韩国常染色体显性多囊肾病患者快速进展的良好预测指标:KNOW-CKD研究结果
Kidney Res Clin Pract. 2022 Jul;41(4):432-441. doi: 10.23876/j.krcp.21.261. Epub 2022 Mar 3.
10
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International.托伐普坦治疗常染色体显性遗传性多囊肾病的应用进展:代表欧洲肾脏协会遗传性肾脏疾病工作组、欧洲罕见肾脏疾病参考网络和多囊肾病国际组织的共识声明。
Nephrol Dial Transplant. 2022 Apr 25;37(5):825-839. doi: 10.1093/ndt/gfab312.
在常染色体显性多囊肾病中,基线总肾体积和肾脏生长速度与慢性肾脏病进展相关。
Kidney Int. 2018 Mar;93(3):691-699. doi: 10.1016/j.kint.2017.09.027. Epub 2017 Dec 28.
4
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease.总肾体积是常染色体显性多囊肾病患者肾功能下降及进展至终末期肾病的预后生物标志物。
Kidney Int Rep. 2017 Jan 16;2(3):442-450. doi: 10.1016/j.ekir.2017.01.003. eCollection 2017 May.
5
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.托伐普坦治疗晚期常染色体显性遗传性多囊肾病。
N Engl J Med. 2017 Nov 16;377(20):1930-1942. doi: 10.1056/NEJMoa1710030. Epub 2017 Nov 4.
6
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.常染色体显性遗传多囊肾病和肝病的遗传复杂性。
J Am Soc Nephrol. 2018 Jan;29(1):13-23. doi: 10.1681/ASN.2017050483. Epub 2017 Oct 16.
7
Molecular diagnosis of autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病的分子诊断。
Expert Rev Mol Diagn. 2017 Oct;17(10):885-895. doi: 10.1080/14737159.2017.1358088. Epub 2017 Aug 13.
8
Performance of an Artificial Multi-observer Deep Neural Network for Fully Automated Segmentation of Polycystic Kidneys.用于多囊肾全自动分割的人工多观察者深度神经网络的性能
J Digit Imaging. 2017 Aug;30(4):442-448. doi: 10.1007/s10278-017-9978-1.
9
Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.图像纹理特征可预测常染色体显性多囊肾病患者的肾功能下降。
Kidney Int. 2017 Nov;92(5):1206-1216. doi: 10.1016/j.kint.2017.03.026. Epub 2017 May 20.
10
Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment.常染色体显性多囊肾病中全肾体积定量方法的比较用于全面疾病评估
Am J Nephrol. 2017;45(5):373-379. doi: 10.1159/000466709. Epub 2017 Mar 18.